Professor Lillian Siu talks to ecancertv about the upcoming Targeted Anticancer Therapies Congress (TAT 2015) and outlines the sessions she is most looking forward to. In particular, she is interested in talks about immune-based therapies and will chair a meeting about the different ways in which efficacy can be, and perhaps should be, assessed.